Mid-Infrared Spectroscopy as a New Tool for Ruling Out Spontaneous Bacterial Peritonitis: A Proof-of-Concept Study.

ascites fluid cirrhosis infection mid-infrared spectroscopy spontaneous bacterial peritonitis

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
09 Mar 2023
Historique:
received: 22 01 2023
revised: 01 03 2023
accepted: 06 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

A highly sensitive and specific point-of-care method for diagnosing spontaneous bacterial peritonitis (SBP) is currently lacking. The objective of the present study is to evaluate the diagnostic value of a rapid, easy-to-use, mid-infrared fiber evanescent wave spectroscopy (MIR-FEWS) method for ruling out SBP. Cirrhotic patients ( Most of the patients were male (71%). The mean age was 60.25 years. Alcohol-related liver disease was the most common cause of cirrhosis. SBP was observed in 18% of the patients. For the diagnosis of SBP in the calibration and validation groups, respectively, the model gave areas under the receiver operating characteristic curves of 0.87 and 0.89, sensitivities of 90% and 87%, specificities of 78% and 80%, positive predictive values of 48% and 50%, negative predictive values of 97% and 96%, positive likelihood ratio of 4.09 and 4.35, negative likelihood ratio of 0.13 and 0.16, Youden index of 0.68 and 0.67, and correct classification rates of 80% and 81%. The results of this proof-of-concept study show that MIR-FEWS is a highly sensitive diagnostic method for ruling out SBP. The method warrants further investigation.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
A highly sensitive and specific point-of-care method for diagnosing spontaneous bacterial peritonitis (SBP) is currently lacking. The objective of the present study is to evaluate the diagnostic value of a rapid, easy-to-use, mid-infrared fiber evanescent wave spectroscopy (MIR-FEWS) method for ruling out SBP.
PATIENTS AND METHODS METHODS
Cirrhotic patients (
RESULTS RESULTS
Most of the patients were male (71%). The mean age was 60.25 years. Alcohol-related liver disease was the most common cause of cirrhosis. SBP was observed in 18% of the patients. For the diagnosis of SBP in the calibration and validation groups, respectively, the model gave areas under the receiver operating characteristic curves of 0.87 and 0.89, sensitivities of 90% and 87%, specificities of 78% and 80%, positive predictive values of 48% and 50%, negative predictive values of 97% and 96%, positive likelihood ratio of 4.09 and 4.35, negative likelihood ratio of 0.13 and 0.16, Youden index of 0.68 and 0.67, and correct classification rates of 80% and 81%.
CONCLUSION CONCLUSIONS
The results of this proof-of-concept study show that MIR-FEWS is a highly sensitive diagnostic method for ruling out SBP. The method warrants further investigation.

Identifiants

pubmed: 36979817
pii: biomedicines11030838
doi: 10.3390/biomedicines11030838
pmc: PMC10045833
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : "Investments for the Future" LABEX SIGNALIFE; UCAJEDI Investments in the Future project
ID : #ANR-11-LABX-0028-01; #ANR-15-IDEX-01
Organisme : National Research Agency
ID : #ANR-18-CE14-0019-02, #ANR-19-CE14-0044-01

Références

Hepatology. 2021 Aug;74(2):1014-1048
pubmed: 33942342
Neth J Med. 2016 Jul;74(6):257-61
pubmed: 27571723
J Hepatol. 2018 Aug;69(2):406-460
pubmed: 29653741
Hepatology. 2007 May;45(5):1275-81
pubmed: 17464969
Gastroenterology. 2008 Sep;135(3):803-7
pubmed: 18590731
Gut. 2016 Mar;65(3):536-8
pubmed: 26141143
PLoS One. 2017 Oct 11;12(10):e0185997
pubmed: 29020046
JHEP Rep. 2019 Oct 23;1(5):361-368
pubmed: 32039387
Am J Gastroenterol. 2016 Oct;111(10):1402-1409
pubmed: 27619833
Aliment Pharmacol Ther. 2008 Aug 1;28(3):282-8
pubmed: 19086234
Pak J Med Sci. 2016 Nov-Dec;32(6):1484-1488
pubmed: 28083050
World J Hepatol. 2018 Feb 27;10(2):254-266
pubmed: 29527261
Rom J Intern Med. 2021 Nov 20;59(4):345-350
pubmed: 34182617
Joint Bone Spine. 2016 May;83(3):318-23
pubmed: 26677999
World J Gastrointest Pathophysiol. 2012 Oct 15;3(5):92-8
pubmed: 23515243
Hepatol Res. 2019 Jan;49(1):72-81
pubmed: 30084186
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Adv Med Sci. 2014 Mar;59(1):52-6
pubmed: 24797975
Rheumatology (Oxford). 2021 Mar 2;60(3):1158-1165
pubmed: 32885254
Clin Microbiol Infect. 2018 May;24(5):546.e1-546.e8
pubmed: 28818628
Gut Liver. 2016 Jul 15;10(4):624-31
pubmed: 26601826

Auteurs

Marwin A Farrugia (MA)

Service d'Hépatologie, Centre Hospitalier Universitaire, Hôpital Archet 2, 151 Route de Saint-Antoine, 06000 Nice, France.

Maëna Le Corvec (M)

DIAFIR, Avenue Chardonnet, Parc Lorans 26J, 35000 Rennes, France.

Christophe Renou (C)

Centre Hospitalier de Hyères, Bd Maréchal Juin, 83400 Hyères, France.

Jean-Baptiste Nousbaum (JB)

Centre Hospitalier Régional Universitaire de Brest, 2, Avenue Foch, 29609 Brest, France.

Dann J Ouizeman (DJ)

Service d'Hépatologie, Centre Hospitalier Universitaire, Hôpital Archet 2, 151 Route de Saint-Antoine, 06000 Nice, France.

Olivier Sire (O)

IRDL, UMR CNRS 6027, Université Bretagne Sud, 56000 Vannes, France.

Olivier Loréal (O)

NUMECAN, UMR INSERM 1241, Centre Hospitalier Universitaire, 35000 Rennes, France.

Hugues Tariel (H)

DIAFIR, Avenue Chardonnet, Parc Lorans 26J, 35000 Rennes, France.

Jérôme Bernard (J)

DIAFIR, Avenue Chardonnet, Parc Lorans 26J, 35000 Rennes, France.

Thierry Piche (T)

INSERM, U1065, C3M, Université Côte d'Azur, 06000 Nice, France.

Albert Tran (A)

Service d'Hépatologie, Centre Hospitalier Universitaire, Hôpital Archet 2, 151 Route de Saint-Antoine, 06000 Nice, France.
INSERM, U1065, C3M, Université Côte d'Azur, 06000 Nice, France.

Hafid Ait-Oufella (H)

Service de Réanimation Médicale, AP-HP, Hôpital Saint-Antoine, INSERM UMR 991, Inserm U970, Paris Research Cardiovascular Center, Université Pierre et Marie Curie, 75012 Paris, France.

Luce Landraud (L)

Université Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME, Louis Mourier Hospital, 92700 Paris, France.

Philippe Gual (P)

INSERM, U1065, C3M, Université Côte d'Azur, 06000 Nice, France.

Rodolphe Anty (R)

Service d'Hépatologie, Centre Hospitalier Universitaire, Hôpital Archet 2, 151 Route de Saint-Antoine, 06000 Nice, France.
INSERM, U1065, C3M, Université Côte d'Azur, 06000 Nice, France.

Classifications MeSH